Strategic ownership AccessClosure is a cardiovascular and peripheral vascular device manufacturer with a track record of innovative, patient-friendly vascular closure products and strategic acquisition by Cardinal Health, indicating strong distribution leverage and potential for co-selling opportunities with broader Cardinal Health channels.

Expansion potential Strong US presence with growing international distribution for the Mynx product family and exclusive US rights to the Flash Ostial System Dual Balloon Angioplasty Catheter suggest opportunities to cross-sell vascular closure and interventional devices to new markets and hospital networks.

Mid-market focus Small to mid-sized company scale (11-50 employees) combined with moderate revenue signals implies a flexible, fast-moving sales motion ideal for targeted hospital system, cath lab, and vascular center partnerships seeking innovative closure solutions.

Pipeline and protection Historical activity around Mynx Ace launches and regulatory/legal interactions indicate a product-driven sales approach with potential for upsell of newer closure devices or adjunct vascular tools to existing customers and prospects aware of Mynx lineage.

Financial leverage Parent company Cardinal Health backing and a disclosed revenue trajectory alongside modest funding enable access to broader procurement networks, value-based selling on cost-per-procedure savings, and participation in group purchasing and enterprise contracts.